Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus
Primary Purpose
Urinary Calculus
Status
Unknown status
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
progesterone,tamsulosin,propantheline Bromide and nifedipine
Sponsored by
About this trial
This is an interventional treatment trial for Urinary Calculus focused on measuring ESWL, urinary calculus, drugs treat
Eligibility Criteria
Inclusion Criteria:
- From 18 years old to 68 years old,
- urinary calculus could be treated by ESWL,
- the calculus size is from 4-25mm
Exclusion Criteria:
- Less than 18 years old or more than 68 years old,
- the calculus size is from Less than4 or larger than 25mm
Sites / Locations
- The First Affiliated Hospital, ChongQing medical UniversityRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
progesterone,tamsulosin,propantheline Bromide and nifedipine
Arm Description
different effect of these drugs use to treat urinary calculus after ESWL
Outcomes
Primary Outcome Measures
different effect of these drugs use to treat urinary calculus after ESWL
Secondary Outcome Measures
Full Information
NCT ID
NCT01010048
First Posted
November 6, 2009
Last Updated
November 12, 2009
Sponsor
Chongqing Medical University
1. Study Identification
Unique Protocol Identification Number
NCT01010048
Brief Title
Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus
Official Title
the Therapeutic Effect Treated With Tamsulosin After ESWL in Urinary Calculus
Study Type
Interventional
2. Study Status
Record Verification Date
November 2009
Overall Recruitment Status
Unknown status
Study Start Date
October 2009 (undefined)
Primary Completion Date
October 2009 (Anticipated)
Study Completion Date
December 2010 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Chongqing Medical University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to compare the stone clearance rate treated with different drugs after ESWL in urinary calculus,These drugs are often used in urinary calculus,such as progesterone,tamsulosin,propantheline Bromide and nifedipine.In these study the investigators want to investigate different effect of these drugs use to treat urinary calculus after ESWL.
Detailed Description
There is 4 groups in these investigation, group1 urinary calculus treated with ESWL only ,group2 urinary calculus treated with ESWL and tamsulosin,group3 urinary calculus treated with ESWL and progesterone,group4 urinary calculus treated with ESWL ,propantheline Bromide and nifedipine.We want to investigate which one is better or not in urinary calculus treated with ESWL .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Calculus
Keywords
ESWL, urinary calculus, drugs treat
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
progesterone,tamsulosin,propantheline Bromide and nifedipine
Arm Type
Experimental
Arm Description
different effect of these drugs use to treat urinary calculus after ESWL
Intervention Type
Drug
Intervention Name(s)
progesterone,tamsulosin,propantheline Bromide and nifedipine
Intervention Description
clearance rate of stone
Primary Outcome Measure Information:
Title
different effect of these drugs use to treat urinary calculus after ESWL
Time Frame
2weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
68 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
From 18 years old to 68 years old,
urinary calculus could be treated by ESWL,
the calculus size is from 4-25mm
Exclusion Criteria:
Less than 18 years old or more than 68 years old,
the calculus size is from Less than4 or larger than 25mm
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yunfeng He, Doctor
Phone
86-23-89011121
First Name & Middle Initial & Last Name or Official Title & Degree
Xiaohou Wu, Doctor
Phone
86-23-89011122
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
xiaohou wu, doctor
Organizational Affiliation
First Affiliated Hospital of Chongqing Medical University
Official's Role
Study Chair
Facility Information:
Facility Name
The First Affiliated Hospital, ChongQing medical University
City
ChongQing
State/Province
Chongqing
ZIP/Postal Code
400016
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yunfeng He, Doctor
Phone
86-23-89011121
First Name & Middle Initial & Last Name & Degree
Xiaohou Wu, Doctor
Phone
86-23-89011122
12. IPD Sharing Statement
Learn more about this trial
Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus
We'll reach out to this number within 24 hrs